A deep dive into the world of orphan drugs, rare diseases and personalised medicines including the background, evolution and fast growth of the area.
The revolution in drug development that we are living right now and what this means for CROs, CDMOs and vendors in the space.
The scary phase of being a start up along with the importance of having purpose as your motivation and being prepared to step-up.
The non-covid impact of covid of the health of the population and the set-back it caused for small biotechs.
Pearls of wisdom for ambitious young female leaders navigating their careers in the pharma and biopharma space.
Evelyn has over 15 years’ experience in the pharmaceutical industry in both distribution and orphan drug companies, working across supply chain, quality assurance and management roles. Evelyn brings years of experience in manufacturing and distributing orphan and speciality drugs to over 50 countries globally.She specializes in the management of supply via virtual, outsourced models and has been named as both a QP and RP on multiple licenses. She has held various positions in Shire, NPS Pharma and PTC Therapeutics and has designed and ran successful supply chains for different products.Evelyn founded Orphan Drug Consulting in 2017, with the vision of supporting companies across the drug development cycle. She holds a Master of Pharmacy from Robert Gordon University and a Master of Business from the Irish Management Institute. She also acts as Adjunct Associate Professor for the School of Pharmacy, Trinity College, Dublin. In 2022, she was named as a finalist in EY Entrepreneur of the Year.
Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!
Molecule to Market is sponsored and funded by ramarketing. An international content, design and digital agency that helps companies in life sciences, get noticed.